Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
Next >
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
July 17, 2024
Tags
Breaking News: Markets
Biotech and Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Biotech and Pharmaceuticals
UnitedHealth Group Inc
Pfizer Inc
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Healthy Returns
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Companies
Business
Health care industry
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Business News
Investment strategy
Investment Strategy
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
Health care industry
Business
Companies
From
CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
July 08, 2024
Tickers
LAWS
Tags
Interest Rates
Stock markets
Elections
From
CNBC.com News
CNBC Daily Open: French far-right advance blocked
July 07, 2024
Tags
Stock indices and averages
Government and politics
Stock markets
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Diabetes
Personal investing
Health care industry
From
CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
July 04, 2024
Tags
Companies
Health care industry
Health & Science
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
CVS Health Corp
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Gilead Sciences Inc
Health & Science
Viking Therapeutics Inc
From
CNBC.com News
5 things to know before the stock market opens
June 25, 2024
Tags
Nasdaq Inc
Politics
Markets
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
Business News
Asia: Top News and Analysis
Biotechnology
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Pharmaceuticals
Health & Science
Business
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Breaking News: Markets
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
Labor economy
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Pharmaceuticals
Health & Science
CNBC Changemakers
From
CNBC.com News
European stocks set for muted open after European Central Bank cut
June 07, 2024
Tags
World economy
Europe Economy
Novo Nordisk A/S
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Weight management
Health & Science
Social issues
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Health & Science
Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Cramer's Lightning Round: Apple is a buy
May 28, 2024
Tags
Investing
Novo Nordisk A/S
S&P 500
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Markets
Amgen Inc
stocks
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
Breaking News: Technology
Internet
Technology
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Health care industry
Healthy Returns
Health & Science
From
CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
May 21, 2024
Tags
Novo Nordisk A/S
Business News
Business
From
CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
May 20, 2024
Tags
Business News
Novo Nordisk A/S
Enterprise
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
Breaking news
Companies
Business
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Eli Lilly and Co
Alphabet Inc
Science
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Pharmaceuticals
Health & Science
Social issues
From
CNBC.com News
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.